Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
Purchase
Description
Xgeva (denosumab) is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Denosumab is supplied at a concentration of 70 mg/mL as a sterile, preservative-free, clear, colorless to pale yellow solution, which contains acetate (18mM), polysorbate 20 (0.01%), sorbitol (4.6%), Water for Injection and sodium hydroxide to a pH of 5.2.
Properties
Name | Denosumab |
CAS NO. | 615258-40-7 |
Type | Whole antibody |
Source | Human |
Target | RANK ligand |
Clone | Monoclone |
Molecular Weight | 147 kDa |
Formula | C6404H9912N1724O2004S50 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China(Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram(Min. Order).
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Denosumab